| Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection A Ammassari, R Murri, P Pezzotti, MP Trotta, L Ravasio, P De Longis, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 28 (5), 445-449, 2001 | 683 | 2001 |
| Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002 | 677 | 2002 |
| Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons A Ammassari, A Antinori, MS Aloisi, MP Trotta, R Murri, L Bartoli, ... Psychosomatics 45 (5), 394-402, 2004 | 385 | 2004 |
| Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy F Starace, A Ammassari, MP Trotta, R Murri, P De Longis, C Izzo, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S136-S139, 2002 | 366 | 2002 |
| Post-COVID-19 global health strategies: the need for an interdisciplinary approach Aging clinical and experimental research 32 (8), 1613-1620, 2020 | 348 | 2020 |
| Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) A Cingolani, A Antinori, MG Rizzo, R Murri, A Ammassari, F Baldini, ... Aids 16 (3), 369-379, 2002 | 311 | 2002 |
| Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays … A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ... Neurology 48 (3), 687-694, 1997 | 295 | 1997 |
| Patient-reported nonadherence to HAART is related to protease inhibitor levels R Murri, A Ammassari, K Gallicano, A De Luca, A Cingolani, D Jacobson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 24 (2), 123-128, 2000 | 212 | 2000 |
| Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian … A Di Castelnuovo, M Bonaccio, S Costanzo, A Gialluisi, A Antinori, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1899-1913, 2020 | 206 | 2020 |
| Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS … A Antinori, G De Rossi, A Ammassari, A Cingolani, R Murri, D Di Giuda, ... Journal of clinical oncology 17 (2), 554-554, 1999 | 189 | 1999 |
| Attitudes towards anti-SARS-CoV2 vaccination among healthcare workers: results from a national survey in Italy F Di Gennaro, R Murri, FV Segala, L Cerruti, A Abdulle, A Saracino, ... Viruses 13 (3), 371, 2021 | 183 | 2021 |
| Determinants of health-related quality of life in HIV-infected patients R Murri, M Fantoni, C Del Borgo, R Visona, A Barracco, A Zambelli, ... AIDS care 15 (4), 581-590, 2003 | 182 | 2003 |
| AIDS-related focal brain lesions in the era of highly active antiretroviral therapy A Ammassari, A Cingolani, P Pezzotti, A De Luca, R Murri, ML Giancola, ... Neurology 55 (8), 1194-1200, 2000 | 160 | 2000 |
| Neurocognitive performance and quality of life in patients with HIV infection V Tozzi, P Balestra, S Galgani, R Murri, R Bellagamba, P Narciso, ... AIDS research and human retroviruses 19 (8), 643-652, 2003 | 155 | 2003 |
| The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy A De Luca, ML Giancola, A Ammassari, S Grisetti, MG Paglia, M Gentile, ... The Journal of infectious diseases 182 (4), 1077-1083, 2000 | 140 | 2000 |
| Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART V Tozzi, P Balestra, R Murri, S Galgani, R Bellagamba, P Narciso, ... International journal of STD & AIDS 15 (4), 254-259, 2004 | 132 | 2004 |
| Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance A De Luca, A Cingolani, S Di Giambenedetto, MP Trotta, F Baldini, ... The Journal of infectious diseases 187 (12), 1934-1943, 2003 | 124 | 2003 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 122 | 2020 |
| Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota … G Ianiro, R Murri, GD Sciumè, M Impagnatiello, L Masucci, AC Ford, ... Annals of internal medicine 171 (10), 695-702, 2019 | 114 | 2019 |
| Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients S Bellesi, E Metafuni, S Hohaus, E Maiolo, F Marchionni, S D’Innocenzo, ... British journal of haematology 191 (2), 207-211, 2020 | 109 | 2020 |